Skip to main content
Day.News — Local News. Real Community.
COLUMBUS DAY NEWS
Local News. Real Community.
health
1 min read

Vaping Rises Among Non-Smokers in UK, Surpassing Smoking Rates for Second Year

New data indicates one million individuals in the UK, who have no history of smoking, now use e-cigarettes. For the second consecutive year, more people aged 16 and over report vaping than smoking.

10/06/2026 · Washington edition

Advertisement

Advertisement

Why it matters locally: While these statistics are from the UK, they highlight a growing trend in nicotine consumption that public health officials in Washington may monitor for similar patterns in the state's population.

LONDON – Approximately one million people in the United Kingdom who have never smoked now use e-cigarettes, according to recent statistics. This marks the second consecutive year that the number of individuals aged 16 and over who vape has exceeded those who smoke. These figures illustrate a shift in nicotine consumption patterns across the UK population. Researchers gathered the data through surveys and analyses of public health trends. The information provides a snapshot of current e-cigarette use among adults and teenagers in the country.

Related Topics

Editorial Transparency
AI-Generated · Written by National Desk

Article Ratings

Factual
0.0
Likeable
0.0
Bias
0.0
Objective
0.0

How do you feel about this story?

NA

National Desk

Trust 3.1102873 articles8,231,170 views75% fact accuracy
View Profile

Sign in to follow this author from their profile.

Discussion (0)

Join the Conversation

Join the conversation

Sign in to share your thoughts, reply to readers, and like comments.

Sign in to comment
Sort by:
0 comments

No comments yet. Be the first to comment!

Trending Now

Trending stories will appear here.

More from Washington

No other local stories are available right now.

Events & Things to Do

Read section →

Upcoming events will appear here.

Advertisement

Advertisement

Keep Reading

Related Stories

More health stories from Washington

health

Supreme Court Begins Term with Key Arguments, Denies Hundreds of Cases

The Supreme Court began its new term by hearing arguments in two cases on Monday, focusing on climate change liability and veterans' benefits. The court also denied review in hundreds of cases, including disputes over student speech and COVID-19 vaccine mandates. Future arguments will address retirement fund management and federal environmental laws.

Read Story →
health

Trump Administration Finalizes Healthcare Transparency Rule

The Trump administration has issued a final rule regarding transparency in healthcare coverage. Health and Human Services Secretary Robert F. Kennedy Jr. stated the regulation offers a 'clear view of what healthcare actually costs.' This initiative seeks to increase consumer understanding of medical expenses.

Read Story →
health

GLP-1 Medications See Increased Use, Spur Research into New Applications

GLP-1 medications are now used by an estimated one in eight Americans. Researchers continue to investigate new potential applications for these drugs. The expansion in use prompts further questions and research.

Read Story →
health

Bipartisan Concern Grows Over Pharmacy Benefit Managers

Republicans and Democrats alike are directing scrutiny toward pharmacy benefit managers, or PBMs. Tennessee and Arkansas have already implemented regulations targeting these healthcare companies. This convergence of political and public opinion highlights increasing pressure on PBM operations.

Read Story →
health

Voters Seek Clear Policy Details, Economic Security from Candidates

Undecided voters express a desire for candidates to provide specific plans on issues affecting their daily lives. Economic stability and healthcare costs rank among their top concerns. Voters indicate they are looking for substantive proposals rather than broad ideological statements.

Read Story →
health

Eli Lilly's EloraTZP Shows Greater Weight and A1C Reduction in Phase 2b Trial

Eli Lilly's experimental drug EloraTZP, a combination of eloralintide and tirzepatide, demonstrated superior weight loss and A1C reduction compared to tirzepatide 15 mg in a 48-week Phase 2b study. Participants taking EloraTZP lost significantly more weight and saw greater improvements in their blood sugar levels.

Read Story →
Scroll for more stories